Laboratory of Hepatitis and Related Emerging Agents, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
Virol J. 2009 Nov 18;6:204. doi: 10.1186/1743-422X-6-204.
Hepatitis A virus (HAV), an atypical Picornaviridae that causes acute hepatitis in humans, grows poorly in cell culture and in general does not cause cytopathic effect. Foreign sequences have been inserted into different parts of the HAV genome. However, the packaging size limit of HAV has not been determined. The purpose of the present study is to investigate the maximum size of additional sequences that the HAV genome can tolerate without loosing infectivity.
In vitro T7 polymerase transcripts of HAV constructs containing a 456-nt fragment coding for a blasticidin (Bsd) resistance gene, a 1,098-nt fragment coding for the same gene fused to GFP (GFP-Bsd), or a 1,032-nt fragment containing a hygromycin (Hyg) resistance gene cloned into the 2A-2B junction of the HAV genome were transfected into fetal Rhesus monkey kidney (FRhK4) cells. After antibiotic selection, cells transfected with the HAV construct containing the resistance gene for Bsd but not the GFP-Bsd or Hyg survived and formed colonies. To determine whether this size limitation was due to the position of the insertion, a 606 bp fragment coding for the Encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) sequence was cloned into the 5' nontranslated (NTR) region of HAV. The resulting HAV-IRES retained the EMCV IRES insertion for 1-2 passages. HAV constructs containing both the EMCV IRES at the 5' NTR and the Bsd-resistance gene at the 2A-2B junction could not be rescued in the presence of Bsd but, in the absence of antibiotic, the rescued viruses contained deletions in both inserted sequences.
HAV constructs containing insertions of approximately 500-600 nt but not 1,000 nt produced viable viruses, which indicated that the HAV particles can successfully package approximately 600 nt of additional sequences and maintain infectivity.
甲型肝炎病毒(HAV)是一种非典型的微小 RNA 病毒科病毒,可导致人类急性肝炎,其在细胞培养中生长不良,通常不会引起细胞病变效应。已经将外源序列插入 HAV 基因组的不同部位。然而,HAV 的包装大小限制尚未确定。本研究的目的是研究 HAV 基因组可以耐受而不失感染性的额外序列的最大大小。
将含有编码博来霉素(Bsd)抗性基因的 456nt 片段、编码与 GFP 融合的相同基因的 1098nt 片段或含有潮霉素(Hyg)抗性基因的 1032nt 片段的 HAV 构建体的体外 T7 聚合酶转录本转染到恒河猴胎儿肾(FRhK4)细胞中。在用抗生素选择后,转染含有 Bsd 抗性基因但不含有 GFP-Bsd 或 Hyg 的 HAV 构建体的细胞存活并形成集落。为了确定这种大小限制是否是由于插入的位置所致,将编码脑炎心肌炎病毒(EMCV)内部核糖体进入位点(IRES)序列的 606bp 片段克隆到 HAV 的 5'非翻译(NTR)区域。由此产生的 HAV-IRES 在 1-2 个传代中保留了 EMCV IRES 插入。在存在 Bsd 的情况下,不能拯救含有 5'NTR 处的 EMCV IRES 和 2A-2B 连接处的 Bsd 抗性基因的 HAV 构建体,但在没有抗生素的情况下,拯救的病毒在两个插入序列中均缺失。
含有插入物约 500-600nt 但不是 1000nt 的 HAV 构建体产生了有活力的病毒,这表明 HAV 颗粒可以成功包装约 600nt 的额外序列并保持感染性。